Emergent CDMO is dedicated to helping biopharma innovators bring lifesaving therapies to patients around the world. Our development and manufacturing sites in North America and Europe can support early to late stage production of biotherapeutics and vaccines. Whether you’re looking for initial process development support, small volumes of material for clinical trials, or large-scale production for a global commercial therapy, our experienced CDMO team is ready to serve as your trusted guide from molecule to market.
We support a broad portfolio of preclinical through commercial programs with experience in a wide range of platforms and technologies including mammalian, microbial, viral, plasma proteins, and gene therapy.
• Process Development
• Analytical Development
• Formulation Development
• Non-GMP Lab-Scale Manufacturing
Drug Substance Manufacturing
• Upstream & Downstream Processing
• Single-Use Platforms (up to 4000L)
Drug Product Manufacturing
• Vials and prefilled syringes
• Lyophilization Services
• High Containment Filling (viral and non-viral)
• Packaging & Labeling
Company name: Emergent BioSolutions CDMO